Agilent introduces bath-free dissolution apparatus

Published: 3-Nov-2011
Analysis

For testing the release rate of pharmaceutical products

Agilent Technologies has introduced the 709-DS dissolution apparatus, which is used to test the release profile of many dosage forms.

The apparatus has a bath-free design that provides an unobstructed view of the dissolution vessel. It also offers increased efficiency through rapid media heating and elimination of water bath cleaning. Vessel media is heated through Agilent’s direct vessel heating system. The instrument is based on the proven 708-DS platform for consistent performance and offers support for a range of workflows.

Automated sample collection and online ultraviolet dissolution integration are available as options to increase laboratory productivity and efficiency.

  • Companies:
  • Agilent Technologies
See more

You may also like

Analysis

Agilent expands the Dako Omnis family with three new models to meet evolving pathology lab needs

Read more
These new instruments provide labs with the flexibility to tailor their staining solutions according to volume, workflow and diagnostic requirements

Trending Articles

  1. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  2. The SCIEX BioPhase 8800 uses native fluorescence detection for protein-based CE assays SCIEX, a global leader in life science analytical technologies, launches new native fluorescence detection on the BioPhase 8800 system
  3. Ecolab Life Sciences Ecolab Life Sciences is the market leader in the supply of premier contamination control solutions for life science cleanrooms worldwide.
  4. CI Precision CI Precision specialises in the design and manufacture of precision weighing systems for quality assurance in the pharmaceutical manufacturing industry.
  5. Butterworth Laboratories Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are considered leaders in Quality Control Testing, Method Development, Method Validation, Method Transfer, and Stability Testing of pharmaceutical raw materials and finished products

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Analysis

Agilent expands the Dako Omnis family with three new models to meet evolving pathology lab needs

These new instruments provide labs with the flexibility to tailor their staining solutions according to volume, workflow and diagnostic requirements
Analysis

Boosting Sustainability and Efficiency in Pharma Manufacturing - WEBINAR NOW ON DEMAND

Join Agilent Technologies in partnership with Manufacturing Chemist for an in-depth webinar where experts Dr Julia Griffen, Transmission Raman Product Manager and Frederic Prulliere, Raman ID Product Manager explore innovative Raman technologies, including Agilent’s handheld Vaya device with patented SORS technology, which identifies materials through packaging—cutting raw material ID time by 50% and reducing waste
Regulatory

Characterising nitrosamine impurities in sartan compounds with an Agilent GC/TQ system with hydrogen carrier gas

Exploring the analysis of nitrosamine contamination in sartan drugs using Agilent's innovative triple quadrupole (TQ) GC/MS system with hydrogen carrier gas
Analysis

Agilent and GenNext integrate digital technologies to accelerate biopharma research

The combination of the two systems will allow biopharmaceutical researchers to better analyse a protein's structure and function in the lab
Analysis

Agilent's chromatographic technologies make it easier

Don’t miss the opportunity to drive efficiency and reduce operational cost with USP 621 revisions
Analysis

The expert's guide to pharmaceutical impurity analysis

Download new eBook from Agilent now
Analysis

Butterworth continues to invest in new equipment

Butterworth Laboratories provides independent, contract analytical services to the global pharmaceutical industry
Subscribe now